Multiple States Sue Teva Pharmaceutical, 19 Other Generic Drug Manufacturers for Allegedly Inflating Prices

598
SHARE
uBiome founders face fraud charges

A coalition of 44 states filed an antitrust lawsuit against Teva Pharmaceutical, 19 other generic drug manufacturers and 15 individuals.

The coalition, led by Connecticut Attorney General William Tong, alleged that Teva Pharmaceutical and its fellow defendants engaged in a broad conspiracy to inflate and manipulate drug prices. In some cases, the coordinated drug price increases were more than 1,000 percent.

Additionally, the coalition accused the defendants of coordinating a sweeping conspiracy to reduce competition and fix prices for over 100 different generic drugs.

Furthermore, the coalition alleged that the 15 individual senior executive defendants orchestrated the conspiracy. They were responsible for the marketing, sales, pricing and operations of the drug manufacturers.

According to the coalition, the defendants’ alleged conspiracy involved a variety of drugs including antibiotics, beta blocks, non-steroidal anti-inflammatory drugs and treatments for a range of diseases including diabetes, cancers, epilepsy, HIV, etc.

Generic drug industry allegedly committed a multi-billion dollar fraud

In a statement, Attorney General Tong emphasized that they have “hard evidence” and against Teva Pharmaceutical and its fellow defendants.